Stock listing
Alar Pharmaceuticals Inc
Selected listing: 6785 · TPEX · TWD · TW
Alar Pharmaceuticals Inc (TPEx:6785), Health Technology. Latest release Apr 6, 2026: Alar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1…
- Ticker
- TPEx:6785
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TPEx
- Currency
- TWD
About Alar Pharmaceuticals Inc
Alar Pharmaceuticals Inc, trading under the ticker 6785, is a public company based in Taiwan. Alar Pharmaceuticals focuses on the development and commercialization of pharmaceutical products.
Latest news from Alar Pharmaceuticals Inc
Alar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1 Results for Long-Acting Injectable ALA-3000 for Treatment-Resistant Depression
April 6, 2026
Alar Announced Buprenorphine Injectable, ALA-1000, Demonstrated Long-Term Efficacy and Favorable Safety Profile in Canine Osteoarthritis Pain Management
March 16, 2026
Research Alar Pharmaceuticals Inc
Alar Pharmaceuticals Inc company profile
View the public company page for Alar Pharmaceuticals Inc on 6ix.
Alar Pharmaceuticals Inc news
Read company news and market updates connected to Alar Pharmaceuticals Inc.
Alar Pharmaceuticals Inc investor events
Find investor webinars, events, and replay context for Alar Pharmaceuticals Inc.